Columbia Engineering researchers report that they have developed a new experimental pipeline to combine bacterial therapy with current cancer drugs. Their study
Columbia Engineering researchers announce the development of a "cloaking" method that momentarily conceals therapeutic microorganisms from immune function, allowing them to transport medications to tumors and destroy cancer cells more efficiently in mice.
Researchers from Columbia Engineering have developed a system that temporarily disguises therapeutic bacteria from immune systems and allows them to deliver drugs to tumors and kill cancer cells in mice.